Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Endocrine therapies tested against treatment side-effects in premenopausal women
September 29th, 2005
The benefits of endocrine therapies were tested against treatment side-effects in premenopausal women. "Adjuvant endocrine therapies such as tamoxifen, goserelin, and oophorectomy improve survival for premenopausal women diagnosed with early-stage breast cancer. However, these treatments often result in menopausal symptoms, sexual dysfunction, permanent infertility, or the need to delay pregnancy," according to an article published in the journal The Lancet Oncology. B. Thewes and colleagues "aimed to quantify the survival gains that premenopausal patients with early-stage breast cancer require to justify the side-effects and inconvenience of...
Source: Women's Health Weekly (2005-09-29)
|
